Trials / Completed
CompletedNCT00750932
Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis
Study of the Biodistribution of PMN Serine Proteases in Sputum of Patients Affected by Cystic Fibrosis: Towards New Anti-inflammatory Therapies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the proposed project is to characterize the neutrophile proteases which participate in the chronic inflammatory phenomenon associated with the cystic fibrosis and which are responsible for the degradation of the lung tissue. The respiratory failure which results from it is one of main causes of the fatal evolution of this pathology but the anti-inflammatory therapies based on the use of antiproteases targeting specifically the soluble elastase did not end, until now, in the hoped results. The identification of the other noxious targets is a crucial element to give new orientations to the anti-inflammatory strategies based on the administration of antiproteases which remain a promising way.
Conditions
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2008-09-11
- Last updated
- 2017-02-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00750932. Inclusion in this directory is not an endorsement.